Statins in the treatment of autosomal dominant polycystic kidney disease

被引：6

作者：

Ecder, Tevfik ^{[1
]}

机构：

[1] Istanbul Bilim Univ, Div Nephrol, Dept Internal Med, Fac Med, Istanbul, Turkey

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷 / 08期

关键词：

REDUCTASE INHIBITORS; ENDOTHELIAL FUNCTION; RENAL-FUNCTION; LOVASTATIN; SIMVASTATIN; PRAVASTATIN;

D O I：

10.1093/ndt/gfv449

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

aEuro broken vertical bar Will statins take a place in the therapeutic armamentarium of ADPKD? We need large randomized controlled trials to give a clear answer to this question. Until we get this evidence, the decision to use a statin in the management of patients with ADPKD will remain with the physician.aEuro broken vertical bar.

引用

页码：1194 / 1196

页数：3

共 22 条

[1] From Finland to Fatland: Beneficial effects of statins for patients with chronic kidney disease [J].

Afzali, B ;

Haydar, AA ;

Vinen, K ;

Goldsmith, DJA .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2161-2168

[2] Beneficial effects of statins on the kidney: the evidence moves from mouse to man [J].

Afzali, B ;

Haydar, AA ;

Vinen, K ;

Goldsmith, DJA .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1032-1036

[3] Statins-beyond lipids in CKD [J].

Amann, Kerstin ;

Benz, Kerstin .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (02) :407-410

[4] Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease [J].

Cadnapaphornchai, Melissa A. ;

George, Diana M. ;

McFann, Kim ;

Wang, Wei ;

Gitomer, Berenice ;

Strain, John D. ;

Schrier, Robert W. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (05) :889-896

[5] Statin therapy improves brachial artery endothelial function in nephrotic syndrome [J].

Dogra, GK ;

Watts, GF ;

Herrmann, S ;

Thomas, MAB ;

Irish, AB .

KIDNEY INTERNATIONAL, 2002, 62 (02) :550-557

[6] Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease [J].

Ecder, Tevfik .

CURRENT HYPERTENSION REVIEWS, 2013, 9 (01) :2-11

[7] Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on renal function [J].

Epstein, M ;

Campese, VM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :2-14

[8] Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease [J].

Fassett, Robert G. ;

Coombes, Jeff S. ;

Packham, David ;

Fairley, Kenneth F. ;

Kincaid-Smith, Priscilla .

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44 (01) :56-61

[9] EFFECT OF LOVASTATIN ON THE DEVELOPMENT OF POLYCYSTIC KIDNEY-DISEASE IN THE HAN-SPRD RAT [J].

GILE, RD ;

COWLEY, BD ;

GATTONE, VH ;

ODONNELL, MP ;

SWAN, SK ;

GRANTHAM, JJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (03) :501-507

[10] Renal microcirculatory effects of lovastatin in a rat model of reduced renal mass [J].

Glazer, AA ;

Inman, SR ;

Stowe, NT ;

Novick, AC .

UROLOGY, 1997, 50 (05) :812-817

← 1 2 3 →